- An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer.
Hongwen Li et al, 2016, Cancer Biol Ther CrossRef - Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients
Sumi Yun et al, 2017, Gastric Cancer CrossRef - Changing strategies for target therapy in gastric cancer
Suk-young Lee, 2016, WJG CrossRef - null
Shouji Shimoyama, 2017 CrossRef - Molecular classifications of gastric cancers: Novel insights and possible future applications
Silvio Ken Garattini et al, 2017, WJGO CrossRef - Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells
Luchun Li et al, 2017 CrossRef - miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer
Xinliang Zhou et al, 2018, Cancer Gene Ther CrossRef - HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer
Tetsushi Kubota et al, 2018, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef - Biomarkers of gastric cancer: Current topics and future perspective
Tasuku Matsuoka et al, 2018, WJG CrossRef - Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies
Alessandra Raimondi et al, 2018, Pharmacogenomics CrossRef - What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
Giuseppe Tirino et al, 2018, IJMS CrossRef - Gastric cancer: Basic aspects
Henrique O. Duarte et al, 2018, Helicobacter CrossRef - The role of HER3 in gastric cancer
Liying Wang et al, 2014, Biomedicine & Pharmacotherapy CrossRef - Recent advances in the HER2 targeted therapy of gastric cancer
Tasuku Matsuoka, 2015, WJCC CrossRef - Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case
Takuya Saito et al, 2015, Pathol Int CrossRef - null
Milos Dokmanovic et al, 2015 CrossRef - A novel dual EGFR/HER2 inhibitor KU004 induces cell cycle arrest and apoptosis in HER2-overexpressing cancer cells
Chongchong Tian et al, 2015, Apoptosis CrossRef - Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study
Jian He et al, 2015, BMC Cancer CrossRef - Targeting HER 2 and angiogenesis in gastric cancer
G Jomrich et al, 2016, Expert Review of Anticancer Therapy CrossRef - Targeted therapy in gastric cancer
G. Jomrich et al, 2016, Eur Surg CrossRef - A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer
Hiromi Kataoka et al, 2016, Cancer Chemother Pharmacol CrossRef - PRL3-zumab, a first-in-class humanized antibody for cancer therapy
Min Thura et al, 2016 CrossRef - Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines
Julia Kneissl et al, 2017, J Cancer Res Clin Oncol CrossRef - null
Giuseppe Tridente, 2017 CrossRef - Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer
Chiara Arienti et al, 2019, Front. Oncol. CrossRef - Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
Chiara Arienti et al, 2016, Oncotarget CrossRef - ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
Eva A. Ebbing et al, 2016, Oncotarget CrossRef - null
Dhananjay Shukla et al, 2020 CrossRef - Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas
Simonetta M. Leto et al, 2015, Clin Cancer Res CrossRef - null
Gayatri Gouda et al, 2020 CrossRef - MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors
Valentina Angerilli et al, 2021, Biomedicines CrossRef - Clinicopathological profile and its association with peritoneal disease among gastric cancer patients
Pavneet Kohli et al, 2021, Surgical Oncology CrossRef - Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells
Maria Maddalena Laterza et al, 2021, Cancers CrossRef - Molecular Determinants of Gastrointestinal Cancers
Francesca Battaglin et al, 2021, Advances in Oncology CrossRef - Resistance Mechanisms to HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma: A Systematic Review
Dionne Blangé et al, 2022, Cancer Treatment Reviews CrossRef - Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy
Sergio González-Rubio et al, 2022, Nanoscale CrossRef - Long noncoding RNA NONHSAT160169.1 promotes resistance via hsa-let-7c-3p/SOX2 axis in gastric cancer
Xuan Zhao et al, 2023, Sci Rep CrossRef - Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Jiahua Liu et al, 2024, Biomedicine & Pharmacotherapy CrossRef - HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments
Magdalena K. Scheck et al, 2024, Cancers CrossRef